[go: up one dir, main page]

SE9900833D0 - Novel combination - Google Patents

Novel combination

Info

Publication number
SE9900833D0
SE9900833D0 SE9900833A SE9900833A SE9900833D0 SE 9900833 D0 SE9900833 D0 SE 9900833D0 SE 9900833 A SE9900833 A SE 9900833A SE 9900833 A SE9900833 A SE 9900833A SE 9900833 D0 SE9900833 D0 SE 9900833D0
Authority
SE
Sweden
Prior art keywords
novel combination
copd
rhinitis
treatment
pulmonary disease
Prior art date
Application number
SE9900833A
Other languages
Swedish (sv)
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9900833A priority Critical patent/SE9900833D0/en
Publication of SE9900833D0 publication Critical patent/SE9900833D0/en
Priority to PCT/SE2000/000417 priority patent/WO2000053187A1/en
Priority to AU36874/00A priority patent/AU3687400A/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to novel combinations of medicaments useful in the treatment of mild moderate and severe asthma and other respiratory disorders such as rhinitis and chronic obstructive pulmonary disease (COPD).
SE9900833A 1999-03-09 1999-03-09 Novel combination SE9900833D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9900833A SE9900833D0 (en) 1999-03-09 1999-03-09 Novel combination
PCT/SE2000/000417 WO2000053187A1 (en) 1999-03-09 2000-03-02 New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
AU36874/00A AU3687400A (en) 1999-03-09 2000-03-02 New combination of formoterol and mometasone in a pharmaceutical composition fortreating respiratory disorders, such as asthma, rhinitis and copd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900833A SE9900833D0 (en) 1999-03-09 1999-03-09 Novel combination

Publications (1)

Publication Number Publication Date
SE9900833D0 true SE9900833D0 (en) 1999-03-09

Family

ID=20414766

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900833A SE9900833D0 (en) 1999-03-09 1999-03-09 Novel combination

Country Status (3)

Country Link
AU (1) AU3687400A (en)
SE (1) SE9900833D0 (en)
WO (1) WO2000053187A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
US20060257324A1 (en) 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab NEW COMPOUNDS
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AR036358A1 (en) * 2001-08-28 2004-09-01 Schering Corp A DOSE INHALER MEASURES CONTAINING A SUSPENSION FORMULATION IN AEROSOL FOR INHALATION, A PROCESS FOR THE PRODUCTION OF THE FORMULATION, THE PRODUCT AND THE USE OF A FORMULATION FOR THE MANUFACTURE OF AN ASTHMA MEDICINAL PRODUCT
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738635A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR20120015334A (en) * 2009-05-29 2012-02-21 펄 테라퓨틱스 인코포레이티드 Compositions for Respiratory Delivery of Active Agents, and Associated Methods and Systems
SI2482799T1 (en) * 2009-10-02 2014-10-30 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
EP2533765A2 (en) * 2010-01-29 2012-12-19 Mahmut Bilgic Pharmaceutical compositions comprising formoterol and mometasone
EP2968152B2 (en) 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
WO1999000134A1 (en) * 1997-06-27 1999-01-07 Astra Aktiebolag (Publ) New combination of antiasthma medicaments

Also Published As

Publication number Publication date
WO2000053187A1 (en) 2000-09-14
AU3687400A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
MXPA02011311A (en) Novel composition.
SE9900833D0 (en) Novel combination
NO20025220L (en) New procedure
SE0200356D0 (en) Novel use
CY1107696T1 (en) COMBINATION OF EFFECTIVE LOTEPREDNOLIS AND DFHO FOR TREATMENT OF RESPIRATORY DISEASES, ALLERGIC DISEASES, ASTHMA AND COPD
NO20001401L (en) New use of budesonide and formoterol
SE9900834D0 (en) Novel combination
IL165378A0 (en) Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
BG106748A (en) Method and compositions for treating pulmonary diseases
MXPA04007294A (en) Composition for inhalation.
BR9910696A (en) Pharmaceutical compositions
CO5690571A2 (en) SYNERGIC COMBINATION INCLUDING ROFLUMILAS AND (R, R) -FORMOTEROL
BG105080A (en) Substituted beta-diketones and their use
WO2003011294A3 (en) Mucin synthesis inhibitors
SE9901273D0 (en) Novel compounds
YU78800A (en) Substituted beta-diketones and their use
GB0218573D0 (en) Treatment of chronic obstructive pulmonary disease (COPD) and other disorders